Compare ARK Genomic Revolution ETF (ARKG) vs Capital One Financial Corp. (COF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Capital One Financial Corp. — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Capital One Financial Corp. trades at $219.35 (market cap $134.45B). The key difference: Capital One Financial Corp. pays a 1.46% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Capital One Financial Corp. nearer its low. Which is the better fit depends on your goals.
| ARKG | COF | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $44.55 | $257.94 |
52-Week Low | $24.02 | $176.10 |
Market Cap | — | $134.45B |
Dividend Yield | — | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →
